Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples

Srinath Kasturirangan, Tim Reasoner, Philip Schulz, Shanta Boddapati, Sharareh Emadi, Jon Valla, Michael Sierks

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability.

Original languageEnglish (US)
Pages (from-to)463-471
Number of pages9
JournalBiotechnology Progress
Volume29
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Immunoglobulin Fragments
Alzheimer Disease
Antigens
Single-Chain Antibodies
Antibodies
Brain
Amyloid
Bacteriophages
Proteins
Clone Cells

Keywords

  • Antibody libraries
  • Atomic force microscopy
  • Beta-amyloid
  • Biopanning
  • Nanotechnology
  • Oligomeric aggregates
  • Single-chain antibody fragments

ASJC Scopus subject areas

  • Biotechnology

Cite this

Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. / Kasturirangan, Srinath; Reasoner, Tim; Schulz, Philip; Boddapati, Shanta; Emadi, Sharareh; Valla, Jon; Sierks, Michael.

In: Biotechnology Progress, Vol. 29, No. 2, 04.2013, p. 463-471.

Research output: Contribution to journalArticle

Kasturirangan, Srinath ; Reasoner, Tim ; Schulz, Philip ; Boddapati, Shanta ; Emadi, Sharareh ; Valla, Jon ; Sierks, Michael. / Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. In: Biotechnology Progress. 2013 ; Vol. 29, No. 2. pp. 463-471.
@article{41dbb928f8e14754916ec767d332d134,
title = "Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples",
abstract = "We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability.",
keywords = "Antibody libraries, Atomic force microscopy, Beta-amyloid, Biopanning, Nanotechnology, Oligomeric aggregates, Single-chain antibody fragments",
author = "Srinath Kasturirangan and Tim Reasoner and Philip Schulz and Shanta Boddapati and Sharareh Emadi and Jon Valla and Michael Sierks",
year = "2013",
month = "4",
doi = "10.1002/btpr.1698",
language = "English (US)",
volume = "29",
pages = "463--471",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples

AU - Kasturirangan, Srinath

AU - Reasoner, Tim

AU - Schulz, Philip

AU - Boddapati, Shanta

AU - Emadi, Sharareh

AU - Valla, Jon

AU - Sierks, Michael

PY - 2013/4

Y1 - 2013/4

N2 - We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability.

AB - We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability.

KW - Antibody libraries

KW - Atomic force microscopy

KW - Beta-amyloid

KW - Biopanning

KW - Nanotechnology

KW - Oligomeric aggregates

KW - Single-chain antibody fragments

UR - http://www.scopus.com/inward/record.url?scp=84875944407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875944407&partnerID=8YFLogxK

U2 - 10.1002/btpr.1698

DO - 10.1002/btpr.1698

M3 - Article

C2 - 23359572

AN - SCOPUS:84875944407

VL - 29

SP - 463

EP - 471

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 2

ER -